- Home
- BLTE vs SAH Comparison
BLTE vs SAH Comparison
Compare BLTE & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- SAH
- Stock Information
- Founded
- BLTE 2018
- SAH 1997
- Country
- BLTE United States
- SAH United States
- Employees
- BLTE N/A
- SAH N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- SAH Other Specialty Stores
- Sector
- BLTE Health Care
- SAH Consumer Discretionary
- Exchange
- BLTE Nasdaq
- SAH Nasdaq
- Market Cap
- BLTE 1.7B
- SAH 2.0B
- IPO Year
- BLTE 2022
- SAH 1997
- Fundamental
- Price
- BLTE $57.60
- SAH $54.83
- Analyst Decision
- BLTE Strong Buy
- SAH Buy
- Analyst Count
- BLTE 4
- SAH 6
- Target Price
- BLTE $59.00
- SAH $66.33
- AVG Volume (30 Days)
- BLTE 40.3K
- SAH 133.5K
- Earning Date
- BLTE 11-12-2024
- SAH 10-24-2024
- Dividend Yield
- BLTE N/A
- SAH 2.16%
- EPS Growth
- BLTE N/A
- SAH N/A
- EPS
- BLTE N/A
- SAH 5.43
- Revenue
- BLTE N/A
- SAH $14,065,300,000.00
- Revenue This Year
- BLTE N/A
- SAH N/A
- Revenue Next Year
- BLTE N/A
- SAH $4.02
- P/E Ratio
- BLTE N/A
- SAH $10.21
- Revenue Growth
- BLTE N/A
- SAH N/A
- 52 Week Low
- BLTE $31.01
- SAH $42.57
- 52 Week High
- BLTE $57.82
- SAH $64.68
- Technical
- Relative Strength Index (RSI)
- BLTE 83.16
- SAH 43.28
- Support Level
- BLTE $55.63
- SAH $52.59
- Resistance Level
- BLTE $56.37
- SAH $57.36
- Average True Range (ATR)
- BLTE 1.65
- SAH 1.43
- MACD
- BLTE 0.53
- SAH 0.09
- Stochastic Oscillator
- BLTE 97.94
- SAH 41.25
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About SAH Sonic Automotive Inc.
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 25 EchoPark used-vehicle stores, 16 collision centers, and 13 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 58% of new-vehicle revenue. BMW is the largest brand at about 25%. 2023's revenue was $14.4 billion, with EchoPark's portion totaling $2.4 billion. Sonic bought RFJ Auto in December 2021, which added $3.2 billion in sales.